Economic Impact of Human Gene Patents – CIE IP Australia May 2013

As with all patents, there are challenges and trade-offs when temporary exclusive rights are required to spur innovation — isolated human gene sequence patents are no different. There are varying views on the merits of isolated human gene sequence patents. Where proponents claim that patents are crucial to supporting high risk and high cost medical […]

Strategic Review of Health and Medical Research In Australia

The Strategic Review of Health and Medical Research in Australia was established by the Australian Government in late 2011. The Review was to report early in 2013 and recommend a 10-year strategic health and medical research plan for the nation. The Panel is chaired by 2011 Australian of the Year, Mr Simon McKeon AO. The […]

Health of Australian Science Chief Scientist May 2012

Health of Australian Science – Chief Scientist May 2012

Australia’s Chief Scientist, Professor Ian Chubb today launched the Health of Australian Science report, a comprehensive overview of Australia’s science system, outlining our strengths and vulnerabilities. Speaking at the National Press Club in Canberra, he said that overall, ours was a healthy and robust system, but that some identified challenges would lead to long term […]

2008 ASX IPO Activity Dives in 2008 Deloitte Dec 2008

ASX IPO Activity Dives in 2008 – Deloitte December 2008

The best performing IPO for 2008 was Phosphate Australia, which listed on 1 July after raising $10 million on the back of soaring prices for phosphate, an essential fertiliser input. At one stage, the company had produced a gain of more than 300% for investors, before sliding to 70% at the survey cut off date. […]

Deloitte Technology Fast 50 Australia – November 2008

The Deloitte Technology Fast 50 Australia program recognises and profiles some of Australia’s fastest growing technology companies. The program, now in its eighth year in Australia, ranks fast growing technology companies, public or private, based on percentage revenue growth over three years (2006–2008), and includes all related industry sectors: communications/networking software biotechnology/pharmaceutical internet computers and […]

2008 Biotechnology Intellectual Property Management Manual Sprusons 2008

Biotechnology Intellectual Property Management Manual – Sprusons 2008

Biotechnology is a strategic and fast growing industry in Australia and across the world. In 2008, Australia is home to over 400 biotech firms with total annual revenues of over $3 billion. By 2010, Victoria aims to be among the top five locations for biotechnology worldwide. Victoria is a national leader in science, technology and […]

2008 Innovation Review IBM Submission Apr 2008

Innovation Review – IBM Submission – April 2008

Innovation is the force that will define our competitiveness, drive our economic progress, improve our quality of life, and strengthen our ability to deal with our social problems. In today’s hyper-competitive global economy, science and technology leadership, though very important, is not enough to achieve innovation. It is not enough simply to intensify current stimuli, […]

2007 Science Technology and Industry Scoreboard OECD

Science Technology and Industry Scoreboard – OECD 2007

This eighth edition of the Science Technology and Industry Scoreboard brings together the latest data and indicators on trends in knowledge, on globalisation and on its impact on economic performance in OECD and non-member economies. In this edition, the focus broadens to include emerging countries, with a special focus on the BRICS (Brazil, Russia, India, […]